Tag Archives: ip

Novozymes Loses “Possession” Of Its Enzyme

Posted on November 1, 2013 by Warren Woessner

I am not sure how I missed this decision, which came down on July 22nd, but it offers a rather scary hi-def picture as to where the written description requirement of s. 112 has been and where it is headed. … Continue reading →

Posted in Written Description Requirements (WDR) | Tagged biotechnology, biotechnology law, Federal Circuit, intellectual property, ip, Novozymes, Patent Law, patents, Warren Woessner | 1 Comment

Canada’s ‘’Sister” Prior Art Law Differs From Ours, Eh!

Posted on October 29, 2013 by Warren Woessner

I recently received a well-written post from Smart & Biggar/Feherstonhaugh in Toronto reminding me that a publication by the inventor only shields a later third-party publication from being a bar if the second publication was derived from the inventor and a … Continue reading →

Posted in Int'l Practice and Policy | Tagged AIA, canada, Canada IP, intellectual property, ip, IP law tools, Smart & Biggar, Warren Woessner | Leave a comment

EPO Abolishes Prior “Short” Divisional Guidelines

Posted on October 21, 2013 by Warren Woessner

This is a guest post from Mewburn Ellis of London. The Administrative Council (the governing body of the European Patent Office) has decided at its meeting on 16 October 2013 to change the regulations regarding the deadline for filing divisional … Continue reading →

Posted in EP and UK Practice | Tagged biotechnology law, EPO, intellectual property, ip, Mewburn Ellis, Patent Law, Warren Woessner | Leave a comment

Supreme Court Will Not Review Therasense Standards – Yet

Posted on October 16, 2013 by Warren Woessner

On October 15, 2013, after reviewing the Government’s Amicus Brief (a copy is available at the end of this post), the Supreme Court denied the petition for cert. filed by Sony Computer Entertainment, one of the defendants in 1st Media, … Continue reading →